GLP-1 receptor agonists like semaglutide and tirzepatide are therapeutic medications, not prohibited substances
The DTC preserves the mitotic identity and promotes mitotic division of SPCs through the canonical GLP-1/Notch signaling that is highly conserved in most multi-cellular organisms (Austin and Kimble, 1987)
Semaglutide is not the trade name but the actual name of the medication
Additionally, a rating of each study based upon the number of subjects studied, time interval of testing, dosing, technical parameters that were quantified, etc
GLP-1 RAs are recommended in the treatment guidelines by the American Diabetes Association as well as the American Association of Clinical Endocrinology (AACE) Consensus Statement & European Society of Cardiology for type 2 diabetes mellitus patients with co-morbidities, like established atherosclerotic cardiovascular disease and obesity